Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Changes

12 Dec 2018 07:00

RNS Number : 1674K
Cenkos Securities PLC
12 December 2018
 

 

12 December 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

Directorate Changes

 

The Board of Cenkos Securities plc today announces that Philip Anderson, Chief Financial Officer,

has indicated his intention to step down from the Board to pursue other interests and will leave the

Company on 31 March 2019

 

A process to appoint a successor will commence.

 

The Board would like to thank Philip for his commitment and contribution to the Company and wish

him well in the future.

 

Enquiries:

 

Cenkos Securities plc

Anthony Hotson, Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGMMMZNMMGRZM
Date   Source Headline
11th May 201710:24 amRNSForm 8.5 (EPT/NON-RI)
3rd May 20179:45 amRNSForm 8.5 (EPT/NON-RI)
2nd May 201710:38 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 201710:09 amRNSForm 8.5 (EPT/NON-RI)
25th Apr 201710:10 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20179:30 amRNSForm 8.5 (EPT/NON-RI)
18th Apr 20177:00 amRNSBlock listing Interim Review
13th Apr 201710:05 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 20175:43 pmRNSDirector/PDMR Shareholding
12th Apr 20175:35 pmRNSDirector/PDMR Shareholding
11th Apr 201710:35 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201710:18 amRNSForm 8.5 (EPT/NON-RI)
7th Apr 20174:10 pmRNSAnnual Report and Notice of AGM
4th Apr 201712:07 pmRNSDirectorate Change
4th Apr 201710:26 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201710:04 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20179:58 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20177:00 amRNSFinal Results
30th Mar 201711:06 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 201710:01 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 201710:43 amRNSForm 8.5 (EPT/NON-RI)
27th Mar 201710:17 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201711:18 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201711:15 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201710:29 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201710:14 amRNSForm 8.3 - BowLeven Plc
17th Mar 201711:16 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201710:51 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 201710:08 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 20179:32 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 201710:17 amRNSForm 8.5 (EPT/NON-RI)
9th Mar 20179:40 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 201710:14 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 201710:03 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201610:51 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 20169:52 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201611:10 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 201611:24 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 201612:05 pmRNSForm 8.5 (EPT/NON-RI)
12th Dec 201611:24 amRNSForm 8.5 (EPT/NON-RI)
9th Dec 20169:59 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20169:46 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201610:50 amRNSForm 8.5 (EPT/NON-RI)
25th Nov 20169:49 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20169:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20167:00 amRNSDirectorate Change
18th Nov 201612:07 pmRNSForm 8.5 (EPT/NON-RI)
16th Nov 20169:47 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 201610:11 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20169:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.